Company news

Curvebeam Ai Ltd. (ASX:CVB) news

Curvebeam Ai Ltd. news releases on 6ix. Latest, Sep 17, 2026: Oversubscribed Shortfall Offer & Placement raise 1.75m

View Curvebeam Ai Ltd. →

Press releases & updates

Oversubscribed Shortfall Offer & Placement raise 1.75m

September 17, 2026

FDA 510(k) Clearance CT-based BMD Technology

September 14, 2026

SPP Offer Results

August 31, 2026

Annual Report to shareholders - FY2026

August 30, 2026

CVB Secures 5M Placement & Announces SPP

July 7, 2026

Q3 FY26 Quarterly Results Investor Webinar

April 29, 2026

Commentary to App 4D - Dec 2025 Half Year

February 26, 2026

Appendix 4D - Interim Financial Report - Dec 2025 Half Year

February 26, 2026

Quarterly Activities/Appendix 4C Cash Flow Report

January 28, 2026

Investor Webinar Presentation - Q2 FY26

January 28, 2026

CVB Notified of China ODI Approval for Strategic Investment

January 6, 2026

Investor Webinar Presentation - Q1 FY26 & China

October 29, 2025

CVB Executes Definitive Agreements for Expansion into China

October 29, 2025

Trading Halt Amended

October 28, 2025

Trading Halt

October 28, 2025

Placement Investor Deck

September 29, 2025

CVB Secures Firm Commitments of $6.5m Placement

September 29, 2025

Financial Year 2025 Results Announcement & Summary

August 27, 2025

Preliminary Final Report

August 27, 2025

Investor Presentation - Q4 FY25 Quarterly Update

July 30, 2025

Quarterly Activity Report - Q3 FY25

April 29, 2025

Investor Presentation - Q3 FY25 Quarterly Update

April 29, 2025

Quarterly Appendix 4C Cash Flow Report

April 29, 2025

Vendor Validation of Enhanced HiRise in Final Stages

March 30, 2025

CVB - Commentary to App 4D - Dec 24 Half Year

February 27, 2025

Appendix 4D - Interim Financial Report - Dec 2024 Half Year

February 27, 2025

Investor Presentation - Q2 FY25 Quarterly Update

January 28, 2025

Commercial Agreement with Stryker expanded to Aust & NZ

January 27, 2025

Investor Presentation - Q1 FY24 Quarterly Update

October 30, 2024

Update on validation of the enhanced HiRise

September 24, 2024

Notice of Extraordinary General Meeting/Proxy Form

September 4, 2024

FY2024 Final Audited Results Commentary

August 29, 2024

Successful Completion of Retail Entitlement Offer

August 27, 2024

Retail Entitlement Offer Booklet & Documents

August 7, 2024

Presentation for todays quarterly 4C investor webinar

August 6, 2024

Institutional placement & accelerated part of ANREO complete

August 4, 2024

Investor Presentation - Placement & ANREO

August 1, 2024

Placement & ANREO to raise up to 13.6m

August 1, 2024

FDA clearance received for Enhanced HiRise

July 14, 2024

Sales Update for Q4 FY2024

July 8, 2024

Investor Presentation - Quarterly Update - Q3 FY24

April 29, 2024

CVB - Commentary to App 4D - Dec 23 Half Year

February 28, 2024

Appendix 4D - Interim Financial Report - Dec 2023 Half Year

February 28, 2024

Q2 FY24 Investor Update Presentation for Webinar

January 29, 2024

AGM - CEO Presentation

November 21, 2023

Quarterly Activities Webinar Presentation - Sep 2023 Qtr

October 29, 2023

Summary of Financial Results - FY2023

September 27, 2023